LifeCord
Transfemoral Mitral Chordal Repair System
Startup Seed Health Tech & Life Sciences Est. 2023
🌐 WebsiteLinkedIn
Total Raised
$1.3M
Seed
Last Round
$1.3M
1 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
72/100
News
1
articles
About
LifeCord develops a Transfemoral Mitral Chordal Repair system, addressing the significant challenge of mitral regurgitation.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2C
Tags
healthcarecardiologyheart-diseasessurgery-toolssurgery
Funding & Events
Apr 2024
Seed $1.3M
MEDX Xelerator
News (1)
Nov 19, 2024 · www.calcalistech.com
growth-positive
LifeCord's mitral chordal repair solution offers an alternative to open-heart surgery | CTech
InvestmentPartners
Details
Product Stage
R&D
Employees
1-10
Exact Count
5
District
Center District
Founded
2023
Registrar
516871548
Locations
Ariel Sharon Blvd 8, Or Yehuda, Israel
Links
Website
www.life-cord.com/
LinkedIn
Profile
Admin
Last Update
Jan 6, 2025
Verified by
Matan Eblagon
Missing
sector, description, video or image, markets, not claimed
Team (2)
Yaron David
CEO
Tomer Ben-Yehuda
VP R&D
Internal
Created by
Ortal Wein (ortalw@sncentral.org)
Created
2024-11-27T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)
Finder · LifeCord · 2026